The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 4
  • 1
    Marsh, Brandon George
    Corporate Counsel At Sage Therapeutics, Inc. born in March 1990
    Individual (1 offspring)
    Officer
    2024-10-25 ~ now
    OF - director → CIF 0
  • 2
    Benecchi, Christopher
    Executive born in November 1971
    Individual (1 offspring)
    Officer
    2025-01-31 ~ now
    OF - director → CIF 0
  • 3
    Company Secretarial Department, 280, Bishopsgate, London, United Kingdom
    Corporate (11 parents, 709 offsprings)
    Officer
    2017-03-01 ~ now
    OF - secretary → CIF 0
  • 4
    55 Cambridge Parkway, Cambridge, Ma 02142, United States
    Corporate (1 offspring)
    Person with significant control
    2017-03-01 ~ now
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
    PE - Right to appoint or remove directors → CIF 0
Ceased 3
  • 1
    Cook, Anne Marie
    Business Executive born in October 1961
    Individual
    Officer
    2017-03-01 ~ 2024-10-29
    OF - director → CIF 0
  • 2
    Flanagan, Michael Patrick
    Vp Accounting At Sage Therapeutics, Inc. born in July 1961
    Individual
    Officer
    2024-10-25 ~ 2025-01-21
    OF - director → CIF 0
  • 3
    Iguchi, Kimi Ellen
    Business Executive born in August 1962
    Individual
    Officer
    2017-03-01 ~ 2024-10-29
    OF - director → CIF 0
parent relation
Company in focus

SAGE THERAPEUTICS LIMITED

Standard Industrial Classification
21200 - Manufacture Of Pharmaceutical Preparations
46460 - Wholesale Of Pharmaceutical Goods
Brief company account
Average Number of Employees
32023-01-01 ~ 2023-12-31
22022-01-01 ~ 2022-12-31
Fixed Assets - Investments
39,596 GBP2023-12-31
39,596 GBP2022-12-31
Debtors
Current
1,930,353 GBP2023-12-31
1,586,416 GBP2022-12-31
Cash at bank and in hand
65,603 GBP2023-12-31
6,675 GBP2022-12-31
Current Assets
1,995,956 GBP2023-12-31
1,593,091 GBP2022-12-31
Creditors
Current, Amounts falling due within one year
-269,802 GBP2023-12-31
-146,859 GBP2022-12-31
Net Current Assets/Liabilities
1,726,154 GBP2023-12-31
1,446,232 GBP2022-12-31
Net Assets/Liabilities
1,765,750 GBP2023-12-31
1,485,828 GBP2022-12-31
Equity
Called up share capital
1 GBP2023-12-31
1 GBP2022-12-31
1 GBP2022-01-01
Retained earnings (accumulated losses)
1,765,749 GBP2023-12-31
1,485,827 GBP2022-12-31
1,261,132 GBP2022-01-01
Equity
1,765,750 GBP2023-12-31
1,485,828 GBP2022-12-31
1,261,133 GBP2022-01-01
Profit/Loss
Retained earnings (accumulated losses)
32,035 GBP2023-01-01 ~ 2023-12-31
-7,940 GBP2022-01-01 ~ 2022-12-31
Profit/Loss
32,035 GBP2023-01-01 ~ 2023-12-31
-7,940 GBP2022-01-01 ~ 2022-12-31
Comprehensive Income/Expense
Retained earnings (accumulated losses)
32,035 GBP2023-01-01 ~ 2023-12-31
-7,940 GBP2022-01-01 ~ 2022-12-31
Comprehensive Income/Expense
32,035 GBP2023-01-01 ~ 2023-12-31
-7,940 GBP2022-01-01 ~ 2022-12-31
Equity - Income/Expense Recognised Directly
Retained earnings (accumulated losses)
247,887 GBP2023-01-01 ~ 2023-12-31
232,635 GBP2022-01-01 ~ 2022-12-31
Equity - Income/Expense Recognised Directly
247,887 GBP2023-01-01 ~ 2023-12-31
232,635 GBP2022-01-01 ~ 2022-12-31
Amounts Owed by Group Undertakings
Current
1,888,435 GBP2023-12-31
1,509,625 GBP2022-12-31
Other Debtors
Current
1,742 GBP2023-12-31
2,748 GBP2022-12-31
Prepayments/Accrued Income
Current
29,435 GBP2023-12-31
69,067 GBP2022-12-31
Debtors - Deferred Tax Asset
Current
10,741 GBP2023-12-31
4,976 GBP2022-12-31
Trade Creditors/Trade Payables
Current
2,085 GBP2023-12-31
2,903 GBP2022-12-31
Corporation Tax Payable
Current
61,809 GBP2023-12-31
18,484 GBP2022-12-31
Other Creditors
Current
21,826 GBP2023-12-31
4,848 GBP2022-12-31
Accrued Liabilities/Deferred Income
Current
184,082 GBP2023-12-31
120,624 GBP2022-12-31
Creditors
Current
269,802 GBP2023-12-31
146,859 GBP2022-12-31
  • SAGE THERAPEUTICS LIMITED
    Info
    Registered number 10646688
    C/o Company Secretarial Department, 280 Bishopsgate, London EC2M 4AG
    Private Limited Company incorporated on 2017-03-01 (8 years 3 months). The company status is Active.
    The last date of confirmation statement was made at 2025-02-25
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy policy

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.